Skip to main content

QUEST DIAGNOSTICS INC

For the period ended Dec 31, 2023. Filed Feb 22, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 22, 2024

DGX$258.44-0.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Power of Attorney (included on signature page)

Signatures

Pursuant to the requirements of Sections 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on February 22, 2024.

QUEST DIAGNOSTICS INCORPORATED
(Registrant)
By:/s/ James E. Davis
James E. Davis
Chairman, Chief Executive Officer and President

Each individual whose signature appears below constitutes and appoints Michael E. Prevoznik and Sean D. Mersten, and each of them singly, his or her true and lawful attorneys-in-fact and agents with full power of substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K filed with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all the said attorneys-in-fact and agents or any of them or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities indicated on February 22, 2024.

SignatureCapacity
/s/James E. DavisJames E. DavisChairman, Chief Executive Officer and President; (Principal Executive Officer)
/s/Sam A. SamadSam A. SamadExecutive Vice President and Chief Financial Officer(Principal Financial Officer)
/s/Michael J. DeppeMichael J. DeppeSenior Vice President, Corporate Controller and Chief Accounting Officer(Principal Accounting Officer)
/s/Luiz A. Diaz, Jr.Luiz A. Diaz, Jr.Director
/s/Tracey C. DoiTracey C. DoiDirector
/s/Vicky B. GreggVicky B. GreggDirector
/s/Wright L. Lassiter, IIIWright L. Lassiter, IIIDirector
/s/Timothy L. MainTimothy L. MainDirector
/s/Denise M. MorrisonDenise M. MorrisonDirector
/s/Gary M. PfeifferGary M. PfeifferDirector
/s/Timothy M. RingTimothy M. RingDirector
/s/Gail R. WilenskyGail R. WilenskyDirector
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.